These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 12435668
1. Target site concentrations of ciprofloxacin after single intravenous and oral doses. Brunner M, Stabeta H, Möller JG, Schrolnberger C, Erovic B, Hollenstein U, Zeitlinger M, Eichler HG, Müller M. Antimicrob Agents Chemother; 2002 Dec; 46(12):3724-30. PubMed ID: 12435668 [Abstract] [Full Text] [Related]
2. Penetration of moxifloxacin into peripheral compartments in humans. Müller M, Stass H, Brunner M, Möller JG, Lackner E, Eichler HG. Antimicrob Agents Chemother; 1999 Oct; 43(10):2345-9. PubMed ID: 10508004 [Abstract] [Full Text] [Related]
3. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens. Anadón A, Martínez-Larrañaga MR, Iturbe J, Martínez MA, Díaz MJ, Frejo MT, Martínez M. Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887 [Abstract] [Full Text] [Related]
4. The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po. Catchpole C, Andrews JM, Woodcock J, Wise R. J Antimicrob Chemother; 1994 Jan; 33(1):103-10. PubMed ID: 8157550 [Abstract] [Full Text] [Related]
5. Distribution and antimicrobial activity of ciprofloxacin in human soft tissues. Brunner M, Hollenstein U, Delacher S, Jäger D, Schmid R, Lackner E, Georgopoulos A, Eichler HG, Müller M. Antimicrob Agents Chemother; 1999 May; 43(5):1307-9. PubMed ID: 10223961 [Abstract] [Full Text] [Related]
6. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing. Hollenstein UM, Brunner M, Schmid R, Müller M. Int J Obes Relat Metab Disord; 2001 Mar; 25(3):354-8. PubMed ID: 11319632 [Abstract] [Full Text] [Related]
7. Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers. Schuck EL, Grant M, Derendorf H. J Clin Pharmacol; 2005 Jul; 45(7):822-31. PubMed ID: 15951472 [Abstract] [Full Text] [Related]
8. Pharmacokinetics and burn eschar penetration of intravenous ciprofloxacin in patients with major thermal injuries. Varela JE, Cohn SM, Brown M, Ward CG, Namias N, Spalding PB. J Antimicrob Chemother; 2000 Mar; 45(3):337-42. PubMed ID: 10702553 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications. Ding HZ, Yang GX, Huang XH, Chen ZL, Zeng ZL. J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140 [Abstract] [Full Text] [Related]
10. Oral ciprofloxacin affects the pharmacokinetics of paracetamol in saliva. Issa MM, Nejem RM, El-Abadla NS. Clin Drug Investig; 2006 Jun; 26(4):223-6. PubMed ID: 17163255 [Abstract] [Full Text] [Related]
11. Pharmacokinetics of sarafloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications. Ding HZ, Zeng ZL, Fung KF, Chen ZL, Qiao GL. J Vet Pharmacol Ther; 2001 Oct; 24(5):303-8. PubMed ID: 11696079 [Abstract] [Full Text] [Related]
12. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Zeitlinger MA, Dehghanyar P, Mayer BX, Schenk BS, Neckel U, Heinz G, Georgopoulos A, Müller M, Joukhadar C. Antimicrob Agents Chemother; 2003 Nov; 47(11):3548-53. PubMed ID: 14576116 [Abstract] [Full Text] [Related]
13. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers. Galicia I, Frias-Iniesta J, Carcas AJ, Soto A, Gomez E, Miranda E, Fernandez A, Montuenga C. Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993 [Abstract] [Full Text] [Related]
14. Penetration of doripenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers. Burian B, Zeitlinger M, Donath O, Reznicek G, Sauermann R. Antimicrob Agents Chemother; 2012 Jan; 56(1):532-5. PubMed ID: 22083466 [Abstract] [Full Text] [Related]
15. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis. Montgomery MJ, Beringer PM, Aminimanizani A, Louie SG, Shapiro BJ, Jelliffe R, Gill MA. Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326 [Abstract] [Full Text] [Related]
16. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects. Khan MK, Khan MF. Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412 [Abstract] [Full Text] [Related]
17. Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease. Joukhadar C, Klein N, Frossard M, Minar E, Stass H, Lackner E, Herrmann M, Riedmüller E, Müller M. Clin Pharmacol Ther; 2001 Dec; 70(6):532-9. PubMed ID: 11753269 [Abstract] [Full Text] [Related]
18. Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin. Naber KG, Theuretzbacher U, Moneva-Koucheva G, Stass H. Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):783-9. PubMed ID: 10614952 [Abstract] [Full Text] [Related]
19. Penetration of ciprofloxacin and its desethylenemetabolite into skin in humans after a single oral dose of the parent drug assessed by cutaneous microdialysis. Bielecka-Grzela S, Klimowicz A. J Clin Pharm Ther; 2005 Aug; 30(4):383-90. PubMed ID: 15985052 [Abstract] [Full Text] [Related]
20. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus). Kim MS, Lim JH, Park BK, Hwang YH, Yun HI. J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784 [Abstract] [Full Text] [Related] Page: [Next] [New Search]